29 February 2024
GSK plc (LSE/NYSE: GSK) today confirmed it has reached a confidential settlement with Boyd/Steenvoord, resolving the case filed in California state court. The case,…
29 February 2024 RUFFER INVESTMENT COMPANY LIMITED (a closed-ended investment company incorporated in Guernsey with registration number 41996) (the “Company“) Half-Yearly Financial Report The…
29 February 2024 London Stock Exchange Group plc Directorate Change London Stock Exchange Group plc (“LSEG”) today announces that Ashok Vaswani will step down…
Continued strong performance: accelerating growth, significant strategic progress, substantial returns to shareholders David Schwimmer, CEO said: “2023 was another strong year for LSEG. We…
28 February 2024
28 February 2024 The Renewables Infrastructure Group Limited“TRIG” or “the Company”, a London-listed investment company advised by InfraRed Capital Partners (“InfraRed”) as Investment Manager…
A YEAR OF PROGRESS WITH MID-SINGLE-DIGIT GROWTH IN HEALTH & HYGIENE Adjusted1 IFRS Unaudited £m 2023 vs 20222 Unaudited £m 2023 vs 20222 Full…
27 February 2024
Performance Highlights At At 31 December 2023 31 December 2022 Net assets £2,551,938,000 £2,417,967,000 Net asset value (“NAV”) per ordinary share (“share”) 1,598.0p 1,410.7p…
26 February 2024
26 February 2024 Voydeya recommended for approval in the EU by CHMP as add-on treatment to ravulizumab or eculizumab for adults with PNH who have…